Alpha Tau Medical (DRTS) Operating Income (2021 - 2026)

Alpha Tau Medical (DRTS) has reported Operating Income for 6 consecutive years, with $13.3 million the latest figure, recorded in Q1 2026.

• Quarterly Operating Income rose 43.03% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 25.37% YoY) and the FY2025 annual result came in at $42.3 million, up 17.33% from the prior year.
• Operating Income grew to $13.3 million in Q1 2026 per DRTS's latest filing, from $12.6 million in the prior quarter.
• Over the last five years, Operating Income for DRTS reached as high as $13.3 million in Q1 2026 and fell as low as $7.4 million in Q3 2022.
• A 5-year average of $9.4 million and a median of $8.9 million in 2023 frame the typical range for Operating Income.
• Annual changes were most pronounced in 2022 — Operating Income soared 221.06% — and 2024, when it dropped 7.11%.
• Year by year, Operating Income stood at $8.0 million in 2022, then gained by 24.52% to $9.9 million in 2023, then increased by 3.33% to $10.3 million in 2024, then advanced by 22.66% to $12.6 million in 2025, then rose by 5.64% to $13.3 million in 2026.
• According to Business Quant data, Operating Income over the past three periods registered $13.3 million, $12.6 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.